Skip to main content
. Author manuscript; available in PMC: 2012 Jan 7.
Published in final edited form as: Neurosci Lett. 2010 Oct 14;487(2):158–162. doi: 10.1016/j.neulet.2010.10.013

Figure 2. In vivo pretreatment with ψεRACK reduces cerebral reperfusion after ischemia.

Figure 2

A ψεRACK bolus 30 min before cerebral ischemia reduced post-ischemic cerebral blood flow (CBF). CBF (% of baseline) curves of laser-Doppler flowmetry tracing before, during, and one hour after an ischemic insult produced by bilateral carotid occlusion and systemic hypotension. P<0.05 compared to Tat peptide.